BioSpace News Archive

What is the best way to prevent or even reverse Alzheimer’s disease? That’s the question at the top of many researchers’ minds, especially given all of the recent large Phase 3 failures involving beta-amyloid targeting drugs, the most pursued target to date. This is troubling but not entirely shocking.

The plaintiffs in the case alleged that Forest intentionally attempted to delay and impair generic competition of its immediate-release formulation of Namenda.

For the third part of a six-part series examining the six most in-demand biotech careers, we take a detailed look at the rising career of an operations research analyst.

Respondents who lived in the Biotech Bay area weighed in on who they thought was an Ideal Employer.

Bit bio, a Cambridge University startup, added a number of industry luminaries to its leadership team to support its moonshot goal of developing a scalable platform technology capable of producing any human cell type.

Broadcast via Facebook Live from XXIV World Congress of Neurology, Dubai, UAE, Monday, Oct. 28, 7:15 am EDT

Rentschler Biopharma SE, a world-class contract development and manufacturing organization for biopharmaceuticals, announced that its Chairman of the Board, Prof. Dr. Nikolaus F. Rentschler, together with CEO Dr. Frank Mathias have received the “EY Entrepreneur of the Year” Award 2019 in the category Industry.

BioMed X announced the successful completion of their first research collaboration project with AbbVie in the field of tau-mediated neurodegeneration in Alzheimer’s disease.

STA Pharmaceutical Co., Ltd., – a subsidiary of WuXi AppTec – announced today that its Jinshan manufacturing facility in Shanghai, China has successfully passed an inspection by the European Medicines Agency with no critical and no major findings.

Scientific Posters Showcase Successful Treatment of Complex Wounds using NEOX® Cryopreserved Umbilical Cord Allograft to Accelerate Healing and Restore Function